Cerus (CERS) Other Operating Expenses (2010 - 2023)

Cerus (CERS) reported Other Operating Expenses of $1.6 million for Q3 2023, down 24.81% sequentially from $2.1 million in Q2 2023.

Cerus (CERS) Other Operating Expenses (2010 - 2023) Analysis & Trends

Cerus (CERS) has 8 years of Other Operating Expenses data on file, last reported at $1.6 million in Q3 2023.

For the quarter ending Q3 2023, Other Operating Expenses changed N/A year-over-year to $1.6 million; the trailing twelve-month figure through Jun 2024 stood at $1.6 million (down 24.81% YoY), and the FY2023 full-year result was $3.7 million, changed N/A from the prior year.
Other Operating Expenses retreated to $1.6 million in Q3 2023, from $2.1 million in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $2.1 million in Q2 2023 to a low of $1.6 million in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn
8	Smith & Nephew	26.99 Bn	26.41 Bn	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn
10	Cerus	600.87 Mn	520.44 Mn	27.89 Mn

Download Data